» Articles » PMID: 16227251

A Major Determinant for Membrane Protein Interaction Localizes to the Carboxy-terminal Domain of the Mouse Coronavirus Nucleocapsid Protein

Overview
Journal J Virol
Date 2005 Oct 18
PMID 16227251
Citations 77
Authors
Affiliations
Soon will be listed here.
Abstract

The two major constituents of coronavirus virions are the membrane (M) and nucleocapsid (N) proteins. The M protein is anchored in the viral envelope by three transmembrane segments flanked by a short amino-terminal ectodomain and a large carboxy-terminal endodomain. The M endodomain interacts with the viral nucleocapsid, which consists of the positive-strand RNA genome helically encapsidated by N protein monomers. In previous work with the coronavirus mouse hepatitis virus (MHV), a highly defective M protein mutant, MDelta2, was constructed. This mutant contained a 2-amino-acid carboxy-terminal truncation of the M protein. Analysis of second-site revertants of MDelta2 revealed mutations in the carboxy-terminal region of the N protein that compensated for the defect in the M protein. To seek further genetic evidence corroborating this interaction, we generated a comprehensive set of clustered charged-to-alanine mutants in the carboxy-terminal domain 3 of N protein. One of these mutants, CCA4, had a highly defective phenotype similar to that of MDelta2. Transfer of the CCA4 mutation into a partially diploid MHV genome showed that CCA4 was a loss-of-function mutation rather than a dominant-negative mutation. Analysis of multiple second-site revertants of CCA4 revealed mutations in both the M protein and the N protein that could compensate for the original lesion in N. These data more precisely define the region of the N protein that interacts with the M protein. Further, we found that fusion of domain 3 of the N protein to the carboxy terminus of a heterologous protein caused it to be incorporated into MHV virions.

Citing Articles

SARS-CoV-2 N protein coordinates viral particle assembly through multiple domains.

Han Y, Zhou H, Liu C, Wang W, Qin Y, Chen M J Virol. 2024; 98(11):e0103624.

PMID: 39412257 PMC: 11575404. DOI: 10.1128/jvi.01036-24.


Variant mutation in SARS-CoV-2 nucleocapsid enhances viral infection via altered genomic encapsidation.

Kubinski H, Despres H, Johnson B, Schmidt M, Jaffrani S, Mills M bioRxiv. 2024; .

PMID: 38559000 PMC: 10979914. DOI: 10.1101/2024.03.08.584120.


Crystal structure of the membrane (M) protein from a bat betacoronavirus.

Wang X, Yang Y, Sun Z, Zhou X PNAS Nexus. 2023; 2(2):pgad021.

PMID: 36874273 PMC: 9982069. DOI: 10.1093/pnasnexus/pgad021.


Antiviral drug design based on structural insights into the N-terminal domain and C-terminal domain of the SARS-CoV-2 nucleocapsid protein.

Luan X, Li X, Li Y, Su G, Yin W, Jiang Y Sci Bull (Beijing). 2022; 67(22):2327-2335.

PMID: 36317101 PMC: 9605790. DOI: 10.1016/j.scib.2022.10.021.


Biophysical Modeling of SARS-CoV-2 Assembly: Genome Condensation and Budding.

Li S, Zandi R Viruses. 2022; 14(10).

PMID: 36298645 PMC: 9611094. DOI: 10.3390/v14102089.


References
1.
Maeda J, Maeda A, Makino S . Release of coronavirus E protein in membrane vesicles from virus-infected cells and E protein-expressing cells. Virology. 1999; 263(2):265-72. PMC: 7131035. DOI: 10.1006/viro.1999.9955. View

2.
Masters P, Rottier P . Coronavirus reverse genetics by targeted RNA recombination. Curr Top Microbiol Immunol. 2004; 287:133-59. PMC: 7122231. DOI: 10.1007/3-540-26765-4_5. View

3.
Kuo L, Godeke G, Raamsman M, Masters P, Rottier P . Retargeting of coronavirus by substitution of the spike glycoprotein ectodomain: crossing the host cell species barrier. J Virol. 2000; 74(3):1393-406. PMC: 111474. DOI: 10.1128/jvi.74.3.1393-1406.2000. View

4.
Godeke G, de Haan C, Rossen J, Vennema H, Rottier P . Assembly of spikes into coronavirus particles is mediated by the carboxy-terminal domain of the spike protein. J Virol. 2000; 74(3):1566-71. PMC: 111495. DOI: 10.1128/jvi.74.3.1566-1571.2000. View

5.
Raamsman M, Locker J, de Hooge A, de Vries A, Griffiths G, Vennema H . Characterization of the coronavirus mouse hepatitis virus strain A59 small membrane protein E. J Virol. 2000; 74(5):2333-42. PMC: 111715. DOI: 10.1128/jvi.74.5.2333-2342.2000. View